Flexible Strength. Proven Success.
The VBX Stent Graft treats iliac occlusive disease with proven procedural success and long-term outcomes through strength, flexibility, and accuracy.
≤ 30% residual stenosis due to high radial strength, even in highly calcified and non-compliant lesions*
Median length change was 0 mm, pre-deployed to final implant in the U.S. IDE study.*
All devices successfully delivered to and deployed at target site with no stent dislodgement, including 18% that were contralateral deliveries*
In TASC II C & D lesions 95.3% primary patency*
* Data on file. Based on nine month results from the Gore VBX FLEX IDE Clinical Study (N = 134 subjects) and follow-ups conducted for U.S. FDA approval.
VBX Stent Graft brings advanced technology and a unique design to help you treat a range of challenging anatomies.
Learn more about our Peripheral Portfolio
The GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis adds a new innovative solution to our expanding Peripheral Portfolio, which provides more treatment options for your complex cases. This is the result of a collaborative effort with clinicians to develop advanced offerings designed to meet the needs of patients. Just one more example of how we work to achieve a shared goal. Together. Improving life.
GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis: Additional product features and benefits, configurations, and Instructions for Use
GORE® VIABAHN® Endoprosthesis: View our extremely strong, growing body of clinical data in the category of complex SFA lesions.
GORE® TIGRIS® Vascular Stent: Now FDA Approved - the GORE® TIGRIS® Vascular Stent goes beyond bare metal with advanced technologies to deliver precise placement and conformability in complex anatomies.